Artivion Inc. (CRY)
NYSE: CRY
· Real-Time Price · USD
17.88
0.25 (1.42%)
At close: Jan 24, 2022, 6:00 AM
Artivion Revenue Breakdown
| Period Ending | Dec 31, 2020 |
|---|---|
| Cardiogenesis Revenue | 464K |
| Cardiogenesis Revenue Growth | n/a |
| Domestic Hospitals Revenue | 137.81M |
| Domestic Hospitals Revenue Growth | n/a |
| International Distributor Revenue | 34.43M |
| International Distributor Revenue Growth | n/a |
| International Hospitals Revenue | 80.52M |
| International Hospitals Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2020 |
|---|---|
| Non Us Revenue | 114.95M |
| Non Us Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 54.7M | 51.43M | 50.02M | 49.32M | 48.14M | 50.28M | 51.09M | 57.24M | 50.37M | 38.45M | 41.05M | 38.98M | 38.95M | 51.25M | 39.05M | 40.83M | 38.64M | 36.1M | 33.74M | 32.29M | 39M | 37.61M | 34.26M | 34.62M | 36.52M | 35.63M | 32.87M | 34.73M | 37.35M | 30.2M | 24.76M | 23.39M | 22.87M | 22.25M | 20.59M | 22.44M | 26.27M | 19.14M | 17.49M | 19.33M | 18.97M |
| Selling, General, and Administrative Revenue Growth | +6.37% | +2.82% | +1.41% | +2.46% | -4.26% | -1.60% | -10.74% | +13.65% | +30.97% | -6.33% | +5.30% | +0.07% | -23.99% | +31.24% | -4.35% | +5.67% | +7.02% | +6.99% | +4.51% | -17.21% | +3.70% | +9.78% | -1.05% | -5.19% | +2.50% | +8.39% | -5.34% | -7.02% | +23.69% | +21.97% | +5.84% | +2.26% | +2.81% | +8.03% | -8.22% | -14.61% | +37.28% | +9.40% | -9.48% | +1.89% | n/a |
| Research and Development Revenue | 6.73M | 7.4M | 6.61M | 7.5M | 6.95M | 7.64M | 6.42M | 7.42M | 7.22M | 8.3M | 11.8M | 8.65M | 10.13M | 9.46M | 9.97M | 8.36M | 7.75M | 6.57M | 5.75M | 5.52M | 6.36M | 5.31M | 6.26M | 5.84M | 5.55M | 6.78M | 5.22M | 5.72M | 5.37M | 6.36M | 4.28M | 4.73M | 4.09M | 3.84M | 3.71M | 3.28M | 2.61M | 2.54M | 2.96M | 2.68M | 2.25M |
| Research and Development Revenue Growth | -9.13% | +12.10% | -11.90% | +7.93% | -9.14% | +19.06% | -13.44% | +2.70% | -13.02% | -29.62% | +36.44% | -14.61% | +7.06% | -5.13% | +19.28% | +7.82% | +17.95% | +14.23% | +4.22% | -13.12% | +19.65% | -15.13% | +7.16% | +5.28% | -18.22% | +29.84% | -8.64% | +6.50% | -15.61% | +48.77% | -9.54% | +15.51% | +6.48% | +3.50% | +13.27% | +25.68% | +2.72% | -14.19% | +10.28% | +19.18% | n/a |